These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1430 related articles for article (PubMed ID: 19428094)
1. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094 [TBL] [Abstract][Full Text] [Related]
2. Analysis of FIGO Stage IIIc endometrial cancer patients. McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962 [TBL] [Abstract][Full Text] [Related]
3. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298 [TBL] [Abstract][Full Text] [Related]
4. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
5. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
6. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
7. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
8. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer. Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308 [TBL] [Abstract][Full Text] [Related]
9. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
10. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Ayhan A; Taskiran C; Celik C; Yuce K Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207 [TBL] [Abstract][Full Text] [Related]
11. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082 [TBL] [Abstract][Full Text] [Related]
12. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
13. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
14. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923 [TBL] [Abstract][Full Text] [Related]
15. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [TBL] [Abstract][Full Text] [Related]
16. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319 [TBL] [Abstract][Full Text] [Related]
18. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607 [TBL] [Abstract][Full Text] [Related]
19. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]